BioVie
BIVI
25 hedge funds and large institutions have $195K invested in BioVie in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 29 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.14% more ownership
Funds ownership: 0.07% → 0.21% (+0.14%)
48% less funds holding
Funds holding: 48 → 25 (-23)
79% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 29
89% less capital invested
Capital invested by funds: $1.79M → $195K (-$1.59M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
|
+$79.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$47.8K |
| 3 |
UCMOK
United Capital Management of KS
Salina,
Kansas
|
+$31.9K |
| 4 |
Cerity Partners
New York
|
+$28.6K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$13.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$794K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$294K |
| 3 |
Jane Street
New York
|
-$70.6K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$36.5K |
| 5 |
Goldman Sachs
New York
|
-$24.7K |
BIVI Hedge Fund Activity: Q3 2024 in Review
25 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q3 2024, worth a combined $195K — down 89% from $1.79M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of BIVI and 6 opened new positions — a net loss of 23 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Zullo Investment Group, opening a new position worth an estimated $79.7K. The largest seller was Altium Capital Management, exiting entirely with an estimated $794K sold.
- 25 institutional investors held BioVie (BIVI) as of Q3 2024, down from 48 in Q2 2024.
- Funds reported $195K of BioVie stock for Q3 2024, down 89% quarter-over-quarter.
- 6 funds opened new BioVie positions in Q3 2024 and 29 closed out, a net change of -23 holders.
- The largest BioVie buyer in Q3 2024 was Zullo Investment Group, an estimated $79.7K added.
- The largest BioVie seller in Q3 2024 was Altium Capital Management, an estimated $794K sold.
Based on aggregated 13F filings for Q3 2024.